Clinical trials in follicular lymphoma

Trial Name

Description

Click for more information (external page)

GEN3013

Phase 1/2 study using antibody GEN3013 to target CD20- expressing cells in patients with B cell non-Hodgkin lymphoma

Suitable for patients with B cell non-Hodgkin lymphoma which has come back after previous treatment

ME-401-001

A phase 2 study of a new drug called ME-401 in people with relapsed or refractory follicular lymphoma.

Suitable for patients with lymphoma which has come back after previous treatment

PARADIGME LYMRIT-37-01

A phase 2 trial comparing two different doses of Betalutin and lilotomab

Suitable for patients with lymphoma which has come back after previous treatment

PETReA

A phase 3 trial testing whether PET scans can help make treatment decisions for people with follicular lymhoma

Suitable for patients who haven't yet received any treatment

GO29781

A phase 1/1b trial testing mosunetuzumab, on its own or with atezolizumab.

Suitable for patients with lymphoma which has come back after previous treatment

RiVa

Phase 2 trial testing the combination of rituximab and varlilumab in people with high grade and low grade lymphomas

Suitable for patients with lymphoma which has come back after previous treatment